Asset Management
Build Your Comparison
Side-by-side financial analysisStock Comparison
FHI vs GROW
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
FHI vs GROW — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Asset Management | Asset Management |
| Market Cap | $4.49B | $39M |
| Revenue (TTM) | $1.86B | $11M |
| Net Income (TTM) | $399M | $3M |
| Gross Margin | 51.5% | 64.9% |
| Operating Margin | 27.4% | -1.4% |
| Forward P/E | 11.6x | — |
| Total Debt | $457M | $83K |
| Cash & Equiv. | $584M | $25M |
FHI vs GROW — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Federated Hermes, I… (FHI) | 100 | 249.2 | +149.2% |
| U.S. Global Investo… (GROW) | 100 | 163.2 | +63.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FHI vs GROW
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FHI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 3 yrs, beta 0.70, yield 2.4%
- Rev growth 11.0%, EPS growth 58.8%
- 144.4% 10Y total return vs GROW's 96.0%
GROW is the clearest fit if your priority is value and dividends.
- Better valuation composite
- 2.9% yield, vs FHI's 2.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.0% NII/revenue growth vs GROW's -23.1% | |
| Value | Better valuation composite | |
| Quality / Margins | Efficiency ratio 0.4% vs GROW's 0.8% (lower = leaner) | |
| Stability / Safety | Beta 0.70 vs GROW's 0.73 | |
| Dividends | 2.9% yield, vs FHI's 2.4% | |
| Momentum (1Y) | +43.1% vs GROW's +31.8% | |
| Efficiency (ROA) | Efficiency ratio 0.4% vs GROW's 0.8% |
FHI vs GROW — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FHI vs GROW — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
GROW leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
FHI is the larger business by revenue, generating $1.9B annually — 171.7x GROW's $11M. GROW is the more profitable business, keeping 29.1% of every revenue dollar as net income compared to FHI's 21.4%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.9B | $11M |
| EBITDAEarnings before interest/tax | $527M | -$111,000 |
| Net IncomeAfter-tax profit | $399M | $3M |
| Free Cash FlowCash after capex | $307M | $464,000 |
| Gross MarginGross profit ÷ Revenue | +51.5% | +64.9% |
| Operating MarginEBIT ÷ Revenue | +27.4% | -1.4% |
| Net MarginNet income ÷ Revenue | +21.4% | +29.1% |
| FCF MarginFCF ÷ Revenue | +16.5% | +4.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +1.6% | +8.8% |
Valuation Metrics
GROW leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $4.5B | $39M |
| Enterprise ValueMkt cap + debt − cash | $4.4B | $15M |
| Trailing P/EPrice ÷ TTM EPS | 11.51x | -124.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.56x | — |
| PEG RatioP/E ÷ EPS growth rate | 1.19x | — |
| EV / EBITDAEnterprise value multiple | 7.82x | — |
| Price / SalesMarket cap ÷ Revenue | 2.48x | 4.65x |
| Price / BookPrice ÷ Book value/share | 3.51x | 0.92x |
| Price / FCFMarket cap ÷ FCF | 15.23x | — |
Profitability & Efficiency
FHI leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
FHI delivers a 29.5% return on equity — every $100 of shareholder capital generates $30 in annual profit, vs $7 for GROW. GROW carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to FHI's 0.36x. On the Piotroski fundamental quality scale (0–9), FHI scores 8/9 vs GROW's 2/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +29.5% | +7.0% |
| ROA (TTM)Return on assets | +18.2% | +6.5% |
| ROICReturn on invested capital | +24.1% | -4.7% |
| ROCEReturn on capital employed | +26.3% | -6.2% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 2 |
| Debt / EquityFinancial leverage | 0.36x | 0.00x |
| Net DebtTotal debt minus cash | -$127M | -$24M |
| Cash & Equiv.Liquid assets | $584M | $25M |
| Total DebtShort + long-term debt | $457M | $83,000 |
| Interest CoverageEBIT ÷ Interest expense | 44.07x | 776.00x |
Total Returns (Dividends Reinvested)
FHI leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in FHI five years ago would be worth $20,177 today (with dividends reinvested), compared to $5,846 for GROW. Over the past 12 months, FHI leads with a +43.1% total return vs GROW's +31.8%. The 3-year compound annual growth rate (CAGR) favors FHI at 19.2% vs GROW's 7.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +14.2% | +27.8% |
| 1-Year ReturnPast 12 months | +43.1% | +31.8% |
| 3-Year ReturnCumulative with dividends | +69.2% | +22.5% |
| 5-Year ReturnCumulative with dividends | +101.8% | -41.5% |
| 10-Year ReturnCumulative with dividends | +144.4% | +96.0% |
| CAGR (3Y)Annualised 3-year return | +19.2% | +7.0% |
Risk & Volatility
FHI leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
FHI is the less volatile stock with a 0.70 beta — it tends to amplify market swings less than GROW's 0.73 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FHI currently trades 98.7% from its 52-week high vs GROW's 84.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.70x | 0.73x |
| 52-Week HighHighest price in past year | $59.83 | $3.65 |
| 52-Week LowLowest price in past year | $41.71 | $2.23 |
| % of 52W HighCurrent price vs 52-week peak | +98.7% | +84.9% |
| RSI (14)Momentum oscillator 0–100 | 67.2 | 68.7 |
| Avg Volume (50D)Average daily shares traded | 734K | 28K |
Analyst Outlook
Evenly matched — FHI and GROW each lead in 1 of 2 comparable metrics.
Analyst Outlook
For income investors, GROW offers the higher dividend yield at 2.92% vs FHI's 2.36%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | — |
| Price TargetConsensus 12-month target | $57.50 | — |
| # AnalystsCovering analysts | 21 | — |
| Dividend YieldAnnual dividend ÷ price | +2.4% | +2.9% |
| Dividend StreakConsecutive years of raises | 3 | 0 |
| Dividend / ShareAnnual DPS | $1.40 | $0.09 |
| Buyback YieldShare repurchases ÷ mkt cap | +5.9% | +5.0% |
FHI leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). GROW leads in 2 (Income & Cash Flow, Valuation Metrics). 1 tied.
FHI vs GROW: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is FHI or GROW a better buy right now?
For growth investors, Federated Hermes, Inc.
(FHI) is the stronger pick with 11. 0% revenue growth year-over-year, versus -23. 1% for U. S. Global Investors, Inc. (GROW). Federated Hermes, Inc. (FHI) offers the better valuation at 11. 5x trailing P/E (11. 6x forward), making it the more compelling value choice. Analysts rate Federated Hermes, Inc. (FHI) a "Hold" — based on 21 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — FHI or GROW?
Over the past 5 years, Federated Hermes, Inc.
(FHI) delivered a total return of +101. 8%, compared to -41. 5% for U. S. Global Investors, Inc. (GROW). Over 10 years, the gap is even starker: FHI returned +144. 4% versus GROW's +96. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — FHI or GROW?
By beta (market sensitivity over 5 years), Federated Hermes, Inc.
(FHI) is the lower-risk stock at 0. 70β versus U. S. Global Investors, Inc. 's 0. 73β — meaning GROW is approximately 5% more volatile than FHI relative to the S&P 500. On balance sheet safety, U. S. Global Investors, Inc. (GROW) carries a lower debt/equity ratio of 0% versus 36% for Federated Hermes, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — FHI or GROW?
By revenue growth (latest reported year), Federated Hermes, Inc.
(FHI) is pulling ahead at 11. 0% versus -23. 1% for U. S. Global Investors, Inc. (GROW). On earnings-per-share growth, the picture is similar: Federated Hermes, Inc. grew EPS 58. 8% year-over-year, compared to -126. 6% for U. S. Global Investors, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — FHI or GROW?
Federated Hermes, Inc.
(FHI) is the more profitable company, earning 22. 3% net margin versus -4. 0% for U. S. Global Investors, Inc. — meaning it keeps 22. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FHI leads at 29. 5% versus -35. 3% for GROW. At the gross margin level — before operating expenses — FHI leads at 73. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — FHI or GROW?
All stocks in this comparison pay dividends.
U. S. Global Investors, Inc. (GROW) offers the highest yield at 2. 9%, versus 2. 4% for Federated Hermes, Inc. (FHI).
07Is FHI or GROW better for a retirement portfolio?
For long-horizon retirement investors, Federated Hermes, Inc.
(FHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 70), 2. 4% yield, +144. 4% 10Y return). Both have compounded well over 10 years (FHI: +144. 4%, GROW: +96. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between FHI and GROW?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: FHI is a small-cap deep-value stock; GROW is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.